SEARCH

SEARCH BY CITATION

  • 1
    Umetsu, D. T., McIntire, J. J., Akbari, O., Macaubas, C. and DeKruyff, R. H., Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 2002. 3: 715720.
  • 2
    Hansen, G., Yeung, V. P., Berry, G., Umetsu, D. T. and DeKruyff, R. H., Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18. J. Immunol. 2000. 164: 223230.
  • 3
    Maecker, H. T., Hansen, G., Walter, D. M., DeKruyff, R. H., Levy, S. and Umetsu, D. T., Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J. Immunol. 2001. 166: 959965.
  • 4
    Erb, K. J. and Wohlleben, G., Novel vaccines protecting against the development of allergic disorders: a double-edged sword? Curr. Opin. Immunol. 2002. 14: 633643.
  • 5
    Krug, N., Madden, J., Redington, A. E., Lackie, P., Djukanovic, R., Schauer, U., Holgate, S. T., Frew, A. J. and Howarth, P. H., T cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am. J. Respir. Cell. Mol. Biol. 1996. 14: 319326.
  • 6
    Bryan, S. A., O'Connor, B. J., Matti, S., Leckie, M. J., Kanabar, V., Khan, J., Warrington, S. J., Renzetti, L., Rames, A., Bock, J. A. et al., Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000. 356: 21492153.
  • 7
    Hansen, G., Berry, G., DeKruyff, R. H. and Umetsu, D. T., Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 1999. 103: 175183.
  • 8
    Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B. and Fauci, A. S., Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 1986. 137: 38553860.
  • 9
    Wahl, S. M., Hunt, D. A., Wong, H. L., Dougherty, S., McCartney-Francis, N., Wahl, L. M., Ellingsworth, L., Schmidt, J. A., Hall, G., Roberts, A. B. et al., Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 1988. 140: 30263032.
  • 10
    Espevik, T., Figari, I. S., Shalaby, M. R., Lackides, G. A., Lewis, G. D., Shepard, H. M. and Palladino, M. A., Jr., Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 1987. 166: 571576.
  • 11
    Barral-Netto, M., Barral, A., Brownell, C. E., Skeiky, Y. A., Ellingsworth, L. R., Twardzik, D. R. and Reed, S. G., Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 1992. 257: 545548.
  • 12
    Brandes, M. E., Allen, J. B., Ogawa, Y. and Wahl, S. M., Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 1991. 87: 11081113.
  • 13
    Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A. and Thorbecke, G. J., Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 1991. 88: 29182921.
  • 14
    Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D. et al., Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992. 359: 693699.
  • 15
    Kulkarni, A. B. and Karlsson, S., Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 1993. 143: 39.
  • 16
    Boivin, G. P., Molina, J. R., Ormsby, I., Stemmermann, G. and Doetschman, T., Gastric lesions in transforming growth factor beta-1 heterozygous mice. Lab. Invest. 1996. 74: 513518.
  • 17
    Hansen, G., McIntire, J. J., Yeung, V. P., Berry, G., Thorbecke, G. J., Chen, L., DeKruyff, R. H. and Umetsu, D. T., CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 2000. 105: 6170.
  • 18
    Redington, A. E., Madden, J., Frew, A. J., Djukanovic, R., Roche, W. R., Holgate, S. T. and Howarth, P. H., Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 1997. 156: 642647.
  • 19
    Tang, B., Bottinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J. and Wakefield, L. M., Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 1998. 4: 802807.
  • 20
    Gorelik, L. and Flavell, R. A., Transforming growth factor-beta in T cell biology. Nat. Rev. Immunol. 2002. 2: 4653.
  • 21
    Kitani, A., Fuss, I. J., Nakamura, K., Schwartz, O. M., Usui, T. and Strober, W., Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J. Exp. Med. 2000. 192: 4152.
  • 22
    Blokzijl, A., ten Dijke, P. and Ibanez, C. F., Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes. Curr. Biol. 2002. 12: 3545.
  • 23
    De Winter, H., Elewaut, D., Turovskaya, O., Huflejt, M., Shimeld, C., Hagenbaugh, A., Binder, S., Takahashi, I., Kronenberg, M. and Cheroutre, H., Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterology 2002. 122: 18291841.
  • 24
    Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B. and Kelsall, B., Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J. Immunol. 1998. 160: 57195728.
  • 25
    Schramm, C., Herz, U., Podlech, J., Protschka, M., Finotto, S., Reddehase, M. J., Kohler, H., Galle, P. R., Lohse, A. W. and Blessing, M., TGF-beta regulates airway responses via T cells. J. Immunol. 2003. 170: 13131319.
  • 26
    Vignola, A. M., Chanez, P., Chiappara, G., Merendino, A., Pace, E., Rizzo, A., la Rocca, A. M., Bellia, V., Bonsignore, G. and Bousquet, J., Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am. J. Respir. Crit. Care Med. 1997. 156: 591599.
  • 27
    Minshall, E. M., Leung, D. Y., Martin, R. J., Song, Y. L., Cameron, L., Ernst, P. and Hamid, Q., Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell. Mol. Biol. 1997. 17: 326333.
  • 28
    Chu, H. W., Trudeau, J. B., Balzar, S. and Wenzel, S. E., Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J. Allergy Clin. Immunol. 2000. 106: 11151123.
  • 29
    Luethviksson, B. R. and Gunnlaugsdottir, B., Transforming growth factor-beta as a regulator of site-specific T cell inflammatory response. Scand. J. Immunol. 2003. 58: 129138.
  • 30
    Bartram, U. and Speer, C. P., The role of transforming growth factor beta in lung development and disease. Chest 2004. 125: 754765.
  • 31
    Letterio, J. J. and Roberts, A. B., Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 1998. 16: 137161.
  • 32
    Coker, R. K., Laurent, G. J., Shahzeidi, S., Hernandez-Rodriguez, N. A., Pantelidis, P., du Bois, R. M., Jeffery, P. K. and McAnulty, R. J., Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lung. Eur. Respir. J. 1996. 9: 25012507.
  • 33
    Pelton, R. W., Johnson, M. D., Perkett, E. A., Gold, L. I. and Moses, H. L., Expression of transforming growth factor-beta 1, -beta 2, and -beta 3 mRNA and protein in the murine lung. Am. J. Respir. Cell. Mol. Biol. 1991. 5: 522530.
  • 34
    Magnan, A., Frachon, I., Rain, B., Peuchmaur, M., Monti, G., Lenot, B., Fattal, M., Simonneau, G., Galanaud, P. and Emilie, D., Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells. Thorax 1994. 49: 789792.
  • 35
    de Boer, W. I., van Schadewijk, A., Sont, J. K., Sharma, H. S., Stolk, J., Hiemstra, P. S. and van Krieken, J. H., Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998. 158: 19511957.
  • 36
    Khalil, N., O'Connor, R. N., Flanders, K. C. and Unruh, H., TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell. Mol. Biol. 1996. 14: 131138.
  • 37
    Jagirdar, J., Lee, T. C., Reibman, J., Gold, L. I., Aston, C., Begin, R. and Rom, W. N., Immunohistochemical Localization of Transforming GrowthFactor Beta Isoforms in Asbestos-Related Diseases. Environ. Health Perspect. 1997. 105S: 11971203.
  • 38
    Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y. and Elias, J. A., Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 1999. 103: 779788.
  • 39
    Rankin, J. A., Picarella, D. E., Geba, G. P., Temann, U. A., Prasad, B., DiCosmo, B., Tarallo, A., Stripp, B., Whitsett, J. and Flavell, R. A., Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 1996. 93: 78217825.
  • 40
    Longphre, M., Li, D., Gallup, M., Drori, E., Ordonez, C. L., Redman, T., Wenzel, S., Bice, D. E., Fahy, J. V. and Basbaum, C., Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J. Clin. Invest. 1999. 104: 13751382.
  • 41
    Lee, J. J., McGarry, M. P., Farmer, S. C., Denzler, K. L., Larson, K. A., Carrigan, P. E., Brenneise, I. E., Horton, M. A., Haczku, A., Gelfand, E. W. et al., Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 1997. 185: 21432156.
  • 42
    Grunig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M. and Corry, D. B., Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998. 282: 22612263.
  • 43
    Sugai, M., Gonda, H., Kusunoki, T., Katakai, T., Yokota, Y. and Shimizu, A., Essential role of Id2 in negative regulation of IgE class switching. Nat. Immunol. 2003. 4: 2530.
  • 44
    Koglin, J., Glysing-Jensen, T., Raisanen-Sokolowski, A. and Russell, M. E., Immune sources of transforming growth factor-beta1 reduce transplant arteriosclerosis: insight derived from a knockout mouse model. Circ. Res. 1998. 83: 652660.
  • 45
    Kang, Y., Mariano, J. M., Angdisen, J., Moody, T. W., Diwan, B. A., Wakefield, L. M. and Jakowlew, S. B., Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1. Mol. Carcinog. 2000. 29: 112126.
  • 46
    McKenna, I. M., Ramakrishna, G., Diwan, B. A., Kang, Y., Shiao, Y. H., Wakefield, L. M., Powell, D. A., Anderson, L. M. and Jakowlew, S. B., Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras. Toxicol. Lett. 2001. 123: 151158.
  • 47
    Kang, Y., Ozbun, L. L., Angdisen, J., Moody, T. W., Prentice, M., Diwan, B. A. and Jakowlew, S. B., Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice. Carcinogenesis 2002. 23: 12171227.
  • 48
    Im, Y. H., Kim, H. T., Kim, I. Y., Factor, V. M., Hahm, K. B., Anzano, M., Jang, J. J., Flanders, K., Haines, D. C., Thorgeirsson, S. S. et al., Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. Cancer Res. 2001. 61: 66656668.
  • 49
    Quintanilla, M., Ramirez, J. R., Perez-Gomez, E., Romero, D., Velasco, B., Letarte, M., Lopez-Novoa, J. M. and Bernabeu, C., Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. Oncogene 2003. 22: 59765985.
  • 50
    Brooks, W. W. and Conrad, C. H., Myocardial fibrosis in transforming growth factor beta(1)heterozygous mice. J. Mol. Cell. Cardiol. 2000. 32: 187195.
  • 51
    Geiser, A. G., Zeng, Q. Q., Sato, M., Helvering, L. M., Hirano, T. and Turner, C. H., Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone 1998. 23: 8793.
  • 52
    Krause, T. J., Katz, D., Wheeler, C. J., Ebner, S. and McKinnon, R. D., Increased levels of surgical adhesions in TGFbeta1 heterozygous mice. J. Invest. Surg. 1999. 12: 3138.
  • 53
    Singer, A. J. and Clark, R. A., Cutaneous wound healing. N. Engl. J. Med. 1999. 341: 738746.
  • 54
    Branton, M. H. and Kopp, J. B., TGF-beta and fibrosis. Microbes Infect. 1999. 1: 13491365.
  • 55
    Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B. and Sporn, M. B., Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J. Cell. Physiol. 1989. 138: 7986.
  • 56
    Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G. L., Irvin, C. G. and Gelfand, E. W., Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 1997. 156: 766775.